Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pharming Group (PHGUF)
OTHER OTC:PHGUF
Pharming Group (PHGUF) Stock Price & Analysis
84 Followers
PHGUF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.89 - $1.43
Previous Close$0.94
Volume580.00
Average Volume (3M)2.44K
Market Cap
$636.38M
Enterprise Value$594.50M
Total Cash (Recent Filing)$213.42M
Total Debt (Recent Filing)$171.54M
Price to Earnings (P/E)-61.7
Beta0.78
Next Earnings
Aug 01, 2024Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding671,073,243
10 Day Avg. Volume0
30 Day Avg. Volume2,435
Standard Deviation0.16
R-Squared0.15
Alpha0.00112
Financial Highlights & Ratios
Price to Book (P/B)5.36
Price to Sales (P/S)2.61
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.70
Enterprise Value/Gross Profit2.70
Enterprise Value/Ebitda16.76
Forecast
1Y Price Target
$2.00Price Target Upside109.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Pharming Group News
Bulls Say, Bears Say
Bulls Say
Investment AttractivenessPharming is considered an attractive investment, trading at a low multiple of expected sales with strong growth prospects and a track record of commercial success.
Product PerformanceJoenja sales growth exceeded expectations, confirming an encouraging trajectory for the product's market performance.
Revenue GrowthRuconest revenues increased, driven by increased volumes and a price increase linked to the consumer price index.
Bears Say
Financial PerformanceOperating loss of $16.3m was greater than estimated, due to a lower reported gross margin and continued increases in operating expenses.
Liquidity ConcernsCash position decreased by $11.5m, but was offset by refinancing activities, including issuing a new convertible bond.
Product Launch DelaysThe planned rollout in Europe for Joenja is delayed due to the CHMP review process taking longer than anticipated.
---
Ownership Overview
0.00%
Insiders
2.56% Mutual Funds
2.53% Other Institutional Investors
94.92% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PHGUF FAQ
What was Pharming Group’s price range in the past 12 months?
Pharming Group lowest stock price was $0.89 and its highest was $1.43 in the past 12 months.
What is Pharming Group’s market cap?
Currently, no data Available
When is Pharming Group’s upcoming earnings report date?
Pharming Group’s upcoming earnings report date is Aug 01, 2024 which is in 79 days.
How were Pharming Group’s earnings last quarter?
Pharming Group released its earnings results on May 08, 2024. The company reported -$0.019 earnings per share for the quarter, missing the consensus estimate of $0.001 by -$0.02.
Is Pharming Group overvalued?
According to Wall Street analysts Pharming Group’s price is currently Undervalued.
Does Pharming Group pay dividends?
Pharming Group does not currently pay dividends.
What is Pharming Group’s EPS estimate?
Pharming Group’s EPS estimate is $0.
How many shares outstanding does Pharming Group have?
Pharming Group has 673,441,350 shares outstanding.
What happened to Pharming Group’s price movement after its last earnings report?
Pharming Group reported an EPS of -$0.019 in its last earnings report, missing expectations of $0.001. Following the earnings report the stock price went down -2.083%.
Which hedge fund is a major shareholder of Pharming Group?
Currently, no hedge funds are holding shares in PHGUF
---
Pharming Group Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.00 (109.67% Upside)
$2.00 (109.67% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.65%
12-Months-Change
Fundamentals
Return on Equity
-5.11%
Trailing 12-Months
Asset Growth
4.41%
Trailing 12-Months
Company Description
Pharming Group
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The company offers RUCONEST which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.
---
PHGUF Company Deck
---
PHGUF Earnings Call
Q1 2024
0:00 / 0:00
---
PHGUF Stock 12 Month Forecast
Average Price Target
$2.00
▲(109.67% Upside)
Technical Analysis
Best Analysts Covering PHGUF
1 Year
1 Year Success Rate
0/9 ratings generated profit
1 Year Average Return
-18.14%
reiterated a buy rating 5 days ago
Copying Alistair Campbell's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -18.14% per trade.
---